Loading clinical trials...
Loading clinical trials...
Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia: Experience From Single Center of Pakistan
Conditions
Interventions
Tocilizumab 200 Mg/10 mL (20 Mg/mL) INTRAVEN VIAL (ML)
Locations
1
Pakistan
Shaheed Zulfiqar Ali Bhutto Medical University
Islamabad, Pakistan
Start Date
April 28, 2020
Primary Completion Date
June 22, 2020
Completion Date
June 22, 2020
Last Updated
May 5, 2021
NCT07390071
NCT06447376
NCT06927622
NCT04150913
NCT05531032
NCT04466098
Lead Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions